Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 16, 2026

Barry Silbert Forecasts Up To 10% Of Bitcoin's Market Cap Will Move To Privacy Coins—Crypto Mogul Says Zcash Can Rocket 500x, BTC Won't

View original at finance.yahoo.com
Barry Silbert Forecasts Up To 10% Of Bitcoin's Market Cap Will Move To Privacy Coins—Crypto Mogul Says Zcash Can Rocket 500x, BTC Won't Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Coins such as Zcash have 500x upside potential

    80% confidence

  • Privacy-focused cryptocurrencies are poised to become the next big investment opportunity in the cryptocurrency industry

    80% confidence

  • The recent cryptocurrency crash is a 'gift from the crypto gods' clearing out excess leverage and crap tokens, potentially paving the way for significant capital inflows

    80% confidence

  • Bitcoin lost the plot as an anonymous currency due to the rise of on-chain analytics firms

    80% confidence

  • Bitcoin will not soar 500 times unless the dollar crashes

    80% confidence

  • I am incredibly bullish about Bitcoin as a core part of a diversified portfolio

    80% confidence

  • Bitcoin is likely never going to have any privacy features

    80% confidence

  • I like to invest in projects that I think are transformative

    80% confidence

  • 5-10% of Bitcoin's market cap would rotate into privacy coins, including Zcash

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com